Introduction
국민건강의 행복지킴이 아산제약이 함께 합니다.
History
The era of leap and passion in 2020
Asan Pharmaceutical is a company that specializes in manufacturing and selling in vitro diagnostic and reagents & device, and we are a company that continuously researches and develops.
- 2021
- Jan
- Acquires CE mark on Asan Easy Test Flu/COVID-19 Ag Combo
- 2020
- Jan
- Acquired manufacturing license for export of Asan Easy Test Zika IgG/IgM, Leishmania Ab, Myco Ag (F), Strep A (F), and Myco Ag
- Jan
- Acquired manufacturing license for export of ASAN Helico-Dry
- May
- Classification of medical devices and in vitro diagnostic medical devices
- May
- Acquired manufacturing license for export of Asan Easy Test COVID-19 IgG/IgM
- May
- Transition from medical devices to in vitro diagnostic medical devices
- Aug
- CE marked on ASAN Transport Medium
- Sep
- Acquired manufacturing license for export of Asan qPCR Test COVID-19 Ag
- Sep
- Acquired manufacturing license for ASANPREP™ Viral Nucleic Acid Purification Kit
- Oct
- Acquires manufacturing license for export of Asan Easy Test COVID-19 Ag
- Nov
- Acquired manufacturing license for export of Asan Easy Test Flu/ COVID-19 Ag Combo
- Dec
- Acquires CE mark on Asan qPCR Test COVID-19 Ag
- Dec
- Registered Asan Easy Test COVID-19 Ag in German market
- Dec
- Acquires FDA EUA to ASAN Transport Medium